Leveraging Technology and Incentives to Tackle Depression Care

Depression is a major contributor to mortality, morbidity, disability, and economic costs in the United States. In 2021, 8.3% of US adults, or about 21 million people, had at least one major depressive episode (MDD), resulting in an economic burden of $ 382.4 billion. Medication nonadherence is high, around 50%, with high rates of unfilled […]

Using Technology and Incentives to Enhance OUD Treatment

Opioid Use Disorder (OUD) is a serious and widespread condition affecting millions of individuals across various demographics. In 2022 an estimated 6.1 million people reported having an opioid use disorder. The US economic cost of OUD in 2017 totaled $1,021 billion. It is characterized by the compulsive use of opioids despite harmful consequences, leading to […]

Solving Stimulant Use Disorder Treatment with Technology and Incentives

Stimulant Use Disorder (StUD) is on the rise across the United States, leading to severe physical, psychological, and social consequences. In 2022, more than 10.2 million people aged 12 and older misused stimulants—a class of drugs that includes cocaine, methamphetamine, and prescription stimulants such as attention-deficit/hyperactivity disorder (ADHD) medications. This is an increase of 8.63% […]